Use of SAMA, SABA Linked to Cardiovascular Events, Mortality in Asthma, COPD

FRIDAY, Sept. 11, 2026-- For patients with asthma and chronic obstructive pulmonary disease (COPD), increased use of short-acting muscarinic antagonists (SAMA) or short-acting beta2-agonists (SABA) + SAMA is associated with increased risks for...